Hinge Health (NYSE:HNGE) Now Covered by Bank of America

Bank of America began coverage on shares of Hinge Health (NYSE:HNGE) in a research note published on Monday morning, Marketbeat reports. The firm issued a buy rating and a $42.00 target price on the stock.

Several other equities research analysts also recently issued reports on the company. Needham & Company LLC initiated coverage on Hinge Health in a report on Monday. They issued a “buy” rating and a $47.00 price objective on the stock. KeyCorp initiated coverage on Hinge Health in a report on Monday. They issued an “overweight” rating and a $45.00 price objective on the stock. Wall Street Zen upgraded Hinge Health to a “hold” rating in a report on Monday, June 2nd. Canaccord Genuity Group initiated coverage on Hinge Health in a report on Monday. They issued a “buy” rating and a $52.00 price objective on the stock. Finally, Barclays initiated coverage on Hinge Health in a report on Monday. They issued an “overweight” rating and a $43.00 price objective on the stock. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Trading Up 5.2%

HNGE stock opened at $36.65 on Monday. Hinge Health has a 12-month low of $33.42 and a 12-month high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.